Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy weight-loss drugs.

The truth about the third wheel in the cockpit.

PepsiCo stock remains a "Buy" given its earnings, 2026 growth guidance, rising dividend, and 20x P/E $175 target. Here's what you need to know about PEP.

It's the calm before the storm. March Madness is almost upon us. Here's our latest NBA mock draft, with projections for all ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Midway through the first half of this stuttering Ireland win, which raises further uncomfortable questions about the direction of travel of Andy Farrell’s team, the stadium announcer saw fit to play ...

Detailed price information for Parker-Hannifin Corp (PH-N) from The Globe and Mail including charting and trades.

Let’s dig into the relative performance of ITT (NYSE:ITT) and its peers as we unravel the now-completed Q4 gas and liquid handling earnings season. Gas and liquid handling companies possess the ...

Utopai Studios built a professional-grade cinematic engine that produces stunning long-form AI video—but its learning curve ...

The primary market is set to see the flow of three new IPOs worth Rs 2,300 crore in the week starting from March 16, with two in the mainboard segment and one in the SME segment. This is despite the ...